Home » Products » Anticancer Drugs » Erlonat 150 mg Erlotinib Tablet

Erlonat 150 mg Erlotinib Tablet

Erlonat 150 mg Erlotinib Tablet
Erlonat 150 mg Erlotinib Tablet
Send Inquiry
Product Code : 97
Price And Quantity
  • Minimum Order Quantity
  • 10 Box
  • Price
  • 11900 INR
Product Specifications
  • Drug Type
  • External Use Drugs
  • Physical Form
  • Tablets
  • Function
  • Anti-Cancer
  • Dosage
  • 150mg
  • Suitable For
  • Suitable For All, Aged Person, Adults, Women, Teenagers
  • Storage Instructions
  • Dry Palace
Product Description

ERLONAT COMMON SIDE EFFECTS :

Nausea, vomiting, loss of appetite, mouth sores, dry skin, eye dryness/irritation, or unusual eyelash growth may occur. Changes in diet such as eating several small meals or limiting activity may help lessen the chance of nausea. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

Tell your doctor right away if any of these rare but very serious side effects occur: signs of kidney problems (such as change in the amount of urine), black stools, vomit that looks like coffee grounds, easy bleeding/bruising, stomach/abdominal pain, yellowing eyes or skin, dark urine, unusual fatigue, signs of infection (e.g., fever, chills, persistent sore throat), eye pain, vision changes.

This is not a complete list of possible side effects. If you notice other eff

WHAT IS ERLONAT ?

ERLONAT is a targeted therapy. Erlonat is classified as a epidermal growth factor receptor (EGFR) inhibitor - protein-tyrosine kinase inhibitor. It works by helping to stop cancer cells from growing.

 

Trade Information
  • Payment Terms
  • Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Cheque, Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 100 Box Per Day
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India

3S CORPORATION
X


Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.